| Dosage Forms and Drug Carrier Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Compatibility of Active Pharmaceutical Ingredients Combinations Compounded in Cleoderm™, a Cream Base for Personalized Dermatological Treatments
Marianni Bruna, Silva Carolina Costa Vicente, Polonini Hudson
|
Mar/Apr 2025
Pg. 150-162
|
Assessing the Compatibility of Different Formulations in OrPhyllo™, A Ready-to-Use Base for Personalized Orodispersible Films
Marianni Bruna, Polonini Hudson, Koulouridas Savvas
|
Mar/Apr 2025
Pg. 163-175
|
K-Carrageenan-Tapioca Starch-Based Vegetable Capsules: A Sustainable Gelatin Alternative-Compounding and Characterization Study
Kumaravelrajan Rajagopal, Arockiyasamy Kishore metha, Venkatesan Suba, Thiraviam Purushoth Prabhu
|
Jan/Feb 2025
Pg. 14-21
|
Calculations - Salicylic Acid Ointments - Percent Strength of a Semisolid Dosage Form, Alligation Alternate Method of Calculation, Temperature Conversion
Stockton Shelly J
|
Jan/Feb 2025
Pg. 40
|
Extemporaneous Compounding of Medicated Ointments
Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
|
Nov/Dec 2024
Pg. 460-467
|
Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2024
Pg. 358-362
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 296-297
|
Compounding and Characterization of a Selfmicroemulsifying System of Ticagrelor Tablets for Enhanced Solubility
Kumaravelrajan Rajagopal, Naresh Narayanan, Mohanta Guru Prasad, Venkatesan Suba, Prasad Pasupuleti Dharani
|
May/Jun 2024
Pg. 194-204
|
Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L, Williams LaVonn A
|
May/Jun 2024
Pg. 226-227
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 243
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 244
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 245
|
Magic Mouthwashes- A Literature Review and Discussion of Common Compositions
McElhiney Linda F
|
Mar/Apr 2024
Pg. 94-98
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Mar/Apr 2024
Pg. 100-109
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
Mar/Apr 2024
Pg. 118-119
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 130
|
Analgesic Compound Lotion, Clear
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 132
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 133
|
Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 134
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 135
|
Hydrophilic Ready-to-use Vehicles and Compounded Topical Medications
Spennacchio Antonio, Lacassia Chiara, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Mar/Apr 2024
Pg. 138-145
|
Lipophilic Ready-to-use Vehicles and Compounded Topical Medications
Lacassia Chiara, Spennacchio Antonio, Lopalco Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Mar/Apr 2024
Pg. 146-150
|
Physical-chemical Stability of the Extemporaneous Paracetamol Oral Suspension in Puccini Base
Lacassia Chiara, Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
|
Mar/Apr 2024
Pg. 151-155
|
Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro™ Cream Base, VersaPro™ Gel Base and PLO Gel Mediflo™ 30 Compound Kit
Friciu Mihaela, Cull Erica, Haiub Halema, Lupatini Rodrigo, Leclair Grégoire
|
Mar/Apr 2024
Pg. 156-160
|
Clinical Safety Profile of TrichoConcept™, a Line of Cosmetic Vehicles for Personalized Treatment of Alopecia
Marianni Bruna, Polonini Hudson, Silva Carolina
|
Mar/Apr 2024
Pg. 169-175
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2024
Pg. 6-14
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jan/Feb 2024
Pg. 16-21
|
Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
|
Jan/Feb 2024
Pg. 28-32
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 474-481
|
Calculations
Stockton Shelly J
|
Nov/Dec 2023
Pg. 488
|
Curcumin 1% Intranasal Mucoadhesive Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 490
|
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 492
|
Salicylic Acid 30% Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 493
|
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
|
Nov/Dec 2023
Pg. 494-502
|
Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics
Rofiq Hanifah Mohd, Phang Hiu Ching, Janakiraman Ashok Kumar, Chew Yik-Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 512-521
|
Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet
Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
|
Nov/Dec 2023
Pg. 522-527
|
Compounding Metformin for Use in Functional Medicine
Desai Sarina, Thompson Tara
|
Sep/Oct 2023
Pg. 362-366
|
Basics of Compounding: Compounding Foams
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 386-395
|
Crotamiton 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 412
|
Fluconazole 1% Thermoresponsive Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 414-415
|
Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 417
|
Povidone Iodine Lotion
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 421
|
Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model
Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
|
Sep/Oct 2023
Pg. 424-430
|
Topical Vehicles: A Dermatologist's Perspective
Adame Stephanie, Collins Michael E, Korman Abraham M
|
Jul/Aug 2023
Pg. 278-283
|
Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 316
|
Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 317-318
|
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 319
|
Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 320-321
|
Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 324-325
|
Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 326
|
Nystatin Oromucosal Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 327
|
Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System
Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
|
Jul/Aug 2023
Pg. 340-346
|
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Touprong Robin, Thompson Tara, Williams LaVonn A
|
May/Jun 2023
Pg. 182-190
|
Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
|
May/Jun 2023
Pg. 218-221
|
Calculations
Stockton Shelly J
|
May/Jun 2023
Pg. 230-231
|
Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2023
Pg. 232-233
|
Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
|
May/Jun 2023
Pg. 235
|
Migraine Headache Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 237
|
Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 238
|
An Alternative Approach to Tablet Splitting and Grinding for Medication Administration
Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
|
May/Jun 2023
Pg. 240-249
|
Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base
Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
|
May/Jun 2023
Pg. 256-262
|
PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 92
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 143
|
Aphthous Ulcer Gel
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 144
|
Cyclosporine Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 146
|
Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 147
|
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 148
|
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 153
|
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
|
Jan/Feb 2023
Pg. 6-10
|
Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery
Rachmawati Putriana
|
Jan/Feb 2023
Pg. 24-29
|
Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 30-37
|
Acetaminophen 10 mg/mL for Rectal Use
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 50
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 52
|
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 53
|
Manning's Liniment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 54
|
Mayer's Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 55
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 56
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 57
|
Suspension Solution, Sugar Free
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 58-59
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 490-495
|
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 508
|
Curcumin 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 509
|
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
|
Nov/Dec 2022
Pg. 516-521
|
PreScription: A New Dosage Form
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 356
|
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
|
Sep/Oct 2022
Pg. 370-377
|
Calculations
Stockton Shelly J
|
Sep/Oct 2022
Pg. 420
|
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 422
|
Clotrimazole 10-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 426
|
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
|
Sep/Oct 2022
Pg. 436-439
|
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules
de Oliveira Ferreira Anderson, Polonini Hudson
|
Jul/Aug 2022
Pg. 283-291
|
Basics: Hollow-type Suppositories
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 302-307
|
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 318
|
Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 320
|
Indomethacin 1% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 325-326
|
Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 327
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 328
|
Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes
Bartoll Aaron Puplà, Bellés Medall Maria Dolores, Peñarrocha Josep Edo, Escrig Laura Solaz, Clemente Ruben Eguren, Azuara Julia Bodega, Piqueres Raul Ferrando
|
Jul/Aug 2022
Pg. 330-335
|
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
|
Jul/Aug 2022
Pg. 336-341
|
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
|
May/Jun 2022
Pg. 189-193
|
A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties
Mady Omar
|
May/Jun 2022
Pg. 195-200
|
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
|
May/Jun 2022
Pg. 214-217
|
Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
|
May/Jun 2022
Pg. 232
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Sirolimus 0.1% Ointment
Allen Loyd V Jr
|
May/Jun 2022
Pg. 240
|
Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
|
May/Jun 2022
Pg. 255-263
|
PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 92
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
|
Mar/Apr 2022
Pg. 110-115
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 141
|
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 142
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 144
|
Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 145
|
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 146
|
Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 147
|
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 149
|
Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates)
Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
|
Mar/Apr 2022
Pg. 150-154
|
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate
Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Mar/Apr 2022
Pg. 155-162
|
Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
|
Mar/Apr 2022
Pg. 163-174
|
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
|
Jan/Feb 2022
Pg. 6-8
|
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
|
Jan/Feb 2022
Pg. 18-23
|
Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 34-38
|
Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 52
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 54
|
Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 55
|
Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 57
|
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
|
Jan/Feb 2022
Pg. 65-71
|
Investigation of the Effects of Excipients in the Compounding of Amlodipine Besylate Orally Disintegrating Tablets
Azmi Nurual Hanisah Saiful, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Jan/Feb 2022
Pg. 80-87
|
Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana
|
Nov/Dec 2021
Pg. 464-467
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie, Wright Edward
|
Nov/Dec 2021
Pg. 482-485
|
Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 500
|
Kayexalate in Lactulose
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 501
|
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 502
|
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 503
|
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 504
|
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 508
|
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 509
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
|
Sep/Oct 2021
Pg. 364-371
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
|
Sep/Oct 2021
Pg. 422-426
|
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Sep/Oct 2021
Pg. 427-430
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
|
Jul/Aug 2021
Pg. 282-287
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 304-309
|
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 320
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 322
|
Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 323
|
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 324
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Moh's Paste, Modified
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 326
|
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 327
|
Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 328
|
Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 329
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Jul/Aug 2021
Pg. 344-351
|
Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
|
May/Jun 2021
Pg. 218-221
|
Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design
Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
|
May/Jun 2021
Pg. 236-240
|
In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester
McKinney Rachael D, Dunbar Jacob R
|
May/Jun 2021
Pg. 241-245
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 126-128
|
Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 142
|
Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 143
|
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 144
|
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 145
|
In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%)
Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
|
Mar/Apr 2021
Pg. 146-155
|
Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes
Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
|
Mar/Apr 2021
Pg. 163-168
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S, Schober Joseph M, McPherson Timothy
|
Jan/Feb 2021
Pg. 48-51
|
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew, Zhao Fang, Dave Vivek S
|
Jan/Feb 2021
Pg. 82-87
|
NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 446-448
|
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 482-490
|
Analysis of Extemporaneously Compounded Nasal Preparations Prescribed by Latvian Otorhinolaryngologists and General Practitioners and Comparison with German Formulations
Kiselova Olga, Maurina Baiba, Sidlovska Venta
|
Nov/Dec 2020
Pg. 491-500
|
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Teimouri Arezou, Yeung Pollen, Agu Remigius U
|
Nov/Dec 2020
Pg. 501-508
|
Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract
Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
|
Nov/Dec 2020
Pg. 509-514
|
Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L.
Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
|
Nov/Dec 2020
Pg. 515-518
|
Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan, Perks William, Law Shirley, Iazzetta John, Walker Scott
|
Nov/Dec 2020
Pg. 519-527
|
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
|
Sep/Oct 2020
Pg. 367-369
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 388-395
|
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 407
|
Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested
Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
|
Sep/Oct 2020
Pg. 408-412
|
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Sep/Oct 2020
Pg. 413-419
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 313
|
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
|
Jul/Aug 2020
Pg. 337-345
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 188-193
|
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III, Everett Eric, Chamberlain Tyler
|
May/Jun 2020
Pg. 194-197
|
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Ngim Kenley, Patel Jalpa
|
May/Jun 2020
Pg. 242-245
|
Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
|
Mar/Apr 2020
Pg. 104-108
|
Calculations
Stockton Shelly J
|
Mar/Apr 2020
Pg. 128
|
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment
Meissner Svenja, Bansal Mahima, Dela Cruz Paula Donamae, Hanning Sara, Svirskis Darren
|
Mar/Apr 2020
Pg. 140-147
|
Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
|
Mar/Apr 2020
Pg. 148-155
|
Feasibility Study of Asthma Cream
Kuang Andrew
|
Mar/Apr 2020
Pg. 163-167
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 59
|
Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 472-477
|
Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
Shakshuki Ayah, Agu Remigius U
|
Nov/Dec 2019
Pg. 496-503
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
|
Sep/Oct 2019
Pg. 376-381
|
Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 393-396
|
Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 399-402
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
|
Jul/Aug 2019
Pg. 288-293
|
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L, York Anne E
|
Jul/Aug 2019
Pg. 325-339
|
Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
|
May/Jun 2019
Pg. 211-216
|
Trends of Extemporaneous Drug Prescription in Latvia in 2017
Kiselova Olga, Maurina Baiba, Sidlovska Venta, Rogovska Irena
|
May/Jun 2019
Pg. 245-249
|
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
|
May/Jun 2019
Pg. 250-257
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
|
Mar/Apr 2019
Pg. 94-104
|
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
|
Mar/Apr 2019
Pg. 113-119
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 150
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 52
|
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 54
|
Orodispersible Film
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 59
|
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Jan/Feb 2019
Pg. 65-69
|
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
|
Jan/Feb 2019
Pg. 77-81
|
Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream
Shakshuki Ayah, Agu Remigius U
|
Jan/Feb 2019
Pg. 82-87
|
Case Study: Absorption of Testosterone Cream via Scrotal Delivery
Needham Shawn, Needham Shane
|
Nov/Dec 2018
Pg. 466-468
|
Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review
Cutaia Kara, Chablani Lipika, Zhao Fang
|
Nov/Dec 2018
Pg. 480-489
|
Calculations
Stockton Shelly J
|
Nov/Dec 2018
Pg. 490
|
Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience
Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2018
Pg. 512-515
|
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
|
Nov/Dec 2018
Pg. 516-526
|
Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 408
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
Stability of Tranexamic Acid Mouth Rinse
Donnelly Ronald F
|
Sep/Oct 2018
Pg. 412-416
|
Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 294-300
|
Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 316
|
Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 317
|
Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson, Carvalho Maria, Banov Fabiana
|
May/Jun 2018
Pg. 182-188
|
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E, Hover Sara, Carvalho Maria
|
May/Jun 2018
Pg. 196-202
|
Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
|
May/Jun 2018
Pg. 220-228
|
Calculations
Stockton Shelly J
|
May/Jun 2018
Pg. 230
|
Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
|
May/Jun 2018
Pg. 232
|
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2018
Pg. 233
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 236
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 238
|
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 239
|
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
|
Mar/Apr 2018
Pg. 108-121
|
Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 137-143
|
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
|
Mar/Apr 2018
Pg. 154-163
|
Topical Ketamine in the Treatment of Complex Regional Pain Syndrome
Durham Melissa J, Mekhjian Hovik S, Goad Jeffery A, Lou Mimi, Ding Michelle, Richeimer Steven H
|
Mar/Apr 2018
Pg. 172-175
|
Sterile Basics of Compounding: Relationship Between Syringe Size and Dosing Accuracy
Kosinski Tracy M, Brown Michael C, Zavala Pedro J
|
Jan/Feb 2018
Pg. 41-46
|
Calculations
Stockton Shelly J
|
Jan/Feb 2018
Pg. 48
|
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 57
|
Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
|
Nov/Dec 2017
Pg. 446-452
|
Orodispersible Films for Compounding Pharmacies
Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2017
Pg. 454-461
|
Basics of Compounding: Hot Melt Extrusion
DePasquale Seth
|
Nov/Dec 2017
Pg. 471-479
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid
Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
|
Nov/Dec 2017
Pg. 500-512
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 416
|
Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 417
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
|
Jul/Aug 2017
Pg. 282-289
|
Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 293-298
|
Basics of Sterile Compounding: Excipients Used in Injections
Akers Michael J
|
Jul/Aug 2017
Pg. 301-308
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 313
|
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 314
|
Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 316
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 321
|
Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia
Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
|
Jul/Aug 2017
Pg. 347-351
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
|
May/Jun 2017
Pg. 215-220
|
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
|
May/Jun 2017
Pg. 242-246
|
Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students
Benischek Rita
|
Mar/Apr 2017
Pg. 105-108
|
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 127-130
|
Accuracy Considerations in Sterile Compounding
Akers Michael J
|
Mar/Apr 2017
Pg. 133-142
|
Calculations
Stockton Shelly J
|
Mar/Apr 2017
Pg. 144
|
Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date
Gautam Pradeep, Light Bob, Purvis Troy
|
Mar/Apr 2017
Pg. 154-159
|
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs
Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
|
Mar/Apr 2017
Pg. 164-170
|
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules
Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid, Polonini Hudson
|
Mar/Apr 2017
Pg. 171-175
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 31-37
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 63
|
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D, Vernak Charlene, Zhao Fang
|
Jan/Feb 2017
Pg. 83-87
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 485-493
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Calculations
Stockton Shelly J
|
Nov/Dec 2016
Pg. 502
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Topical Ketamine 10% for Neuropathic Pain in Spinal Cord Injury Patients: An Open-Label Trial
Rabi Joseph, Minori Joshua, Abad Hasan, Lee Ray, Gittler Michelle
|
Nov/Dec 2016
Pg. 517-520
|
Stability of Ribavirin for Inhalation Packaged in Syringes or Glass Vials when Stored Frozen, Refrigerated, and at Room Temperature
Larson Bayli, Bushman Lane R, Casciano Matthew L, Oldland Alan R, Kiser Jennifer J, Kiser Tyree H
|
Nov/Dec 2016
Pg. 521-525
|
Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 389-396
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Permethrin 1% Lotion
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 411
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
A Simplified Extemporaneously Prepared Potassium Chloride Oral Solution
Tannous Elias, Tal Yana, Amarny Kamal
|
Sep/Oct 2016
Pg. 438-439
|
Compounding Transdermal Medication for Feline Patients
Eichstadt Lauren R
|
Jul/Aug 2016
Pg. 271-274
|
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Calculations
Stockton Shelly J
|
Jul/Aug 2016
Pg. 316-317
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 323
|
Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 324
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Long-term Stability of Vancomycin Hydrochloride in Oral Solution: The Brand Name Versus a Generic Product
Huvelle Sophie, Godet Marie, Hecq Jean-Daniel, Gillet Patricia, Jamart Jacques, Galanti Laurence M
|
Jul/Aug 2016
Pg. 347-350
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
|
May/Jun 2016
Pg. 229
|
Indomethacin Gel
Allen Loyd V Jr
|
May/Jun 2016
Pg. 230
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
May/Jun 2016
Pg. 231
|
Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
|
May/Jun 2016
Pg. 232
|
Pain-Away II Headache Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 233
|
Topical Metered-dosing Dispenser Performance Evaluation
Liu Qiang, Kupiec Thomas C, Vu Nicole T
|
May/Jun 2016
Pg. 239-246
|
Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John, Light Bob
|
May/Jun 2016
Pg. 250-256
|
Topical Ketamine: A Review of the History, Mechanisms, Uses, Safety, and Future
Rabi Joseph
|
Mar/Apr 2016
Pg. 107-113
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Formulation and Stability of Solutions
Akers Michael J
|
Mar/Apr 2016
Pg. 137-141
|
Calculations
Stockton Shelly J
|
Mar/Apr 2016
Pg. 142
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 145
|
Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 146
|
Utilization of Compounded Medications in an Oral Medicine Practice
Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel
|
Mar/Apr 2016
Pg. 155-158
|
Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups
Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
|
Mar/Apr 2016
Pg. 159-163
|
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Nahata Milap C
|
Mar/Apr 2016
Pg. 164-166
|
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
|
Jan/Feb 2016
Pg. 6-10
|
Basic Principles of Lyophilization, Part 2
Akers Michael J
|
Jan/Feb 2016
Pg. 20-27
|
Formulation and Stability of Solutions
Akers Michael J
|
Jan/Feb 2016
Pg. 41-45
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 50
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Mupirocin Calcium 2% Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 52
|
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 53
|
Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 54
|
Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 55
|
A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis
Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
|
Jan/Feb 2016
Pg. 71-80
|
Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
|
Nov/Dec 2015
Pg. 479-484
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 404
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 407
|
Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 408
|
Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 409
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 411
|
Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 412
|
Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 413
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
|
Sep/Oct 2015
Pg. 428-431
|
Balsam Peru, Castor Oil, and Trypsin Ointment
Allen Loyd V
|
Jul/Aug 2015
Pg. 325
|
Proparacaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V
|
Jul/Aug 2015
Pg. 332
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
|
May/Jun 2015
Pg. 223-230
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Stability of Metronidazole Suspensions
Donnelly Ronald F, Ying James
|
May/Jun 2015
Pg. 248-251
|
Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
|
May/Jun 2015
Pg. 252-260
|
Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 145
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
|
Mar/Apr 2015
Pg. 152-160
|
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
|
Mar/Apr 2015
Pg. 161-166
|
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
|
Mar/Apr 2015
Pg. 167-173
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 67
|
Mupirocin 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 68
|
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration
Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J
|
Jan/Feb 2015
Pg. 70-72
|
Stability of Suspensions: Theoretical and Practical Considerations before Compounding
Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
|
Jan/Feb 2015
Pg. 78-85
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula
Sherr Zachary, Karara Adel H
|
Nov/Dec 2014
Pg. 462-468
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
Calculations
Stockton Shelly J
|
Nov/Dec 2014
Pg. 492-493
|
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014
Pg. 504-511
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014
Pg. 516-519
|
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014
Pg. 520-525
|
PreScription: What is a Compounding Pharmacist?
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 356
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
|
Sep/Oct 2014
Pg. 370-377
|
Bacitracin Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 409
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William, Rudner Shara, Kotik Viktoriya
|
Jul/Aug 2014
Pg. 287-290
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 318-319
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Hoffmann Brittany, Carlson Christie, Rao Deepa A
|
Jul/Aug 2014
Pg. 341-344
|
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
Jul/Aug 2014
Pg. 345-347
|
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Addo Richard T
|
Jul/Aug 2014
Pg. 348-350
|
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014
Pg. 213-221
|
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
|
May/Jun 2014
Pg. 228-230
|
Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
|
May/Jun 2014
Pg. 235
|
Dibucaine 1% Ointment
Allen Loyd V Jr
|
May/Jun 2014
Pg. 236
|
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
|
May/Jun 2014
Pg. 248-252
|
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
|
May/Jun 2014
Pg. 256-261
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 137-138
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 42-45
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 490-495
|
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
|
Nov/Dec 2013
Pg. 512-514
|
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan, Black Laura
|
Nov/Dec 2013
Pg. 520-525
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
Chemical Penetration Enhancers
Newton Stephen J
|
Sep/Oct 2013
Pg. 370-374
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Pruitt Bobby N III
|
Sep/Oct 2013
Pg. 384-387
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Sep/Oct 2013
Pg. 412
|
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013
Pg. 424-431
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs
Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
|
Jul/Aug 2013
Pg. 347-350
|
Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
|
May/Jun 2013
Pg. 201-204
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Stability of Minoxidil in Espumil Foam Base
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Mar/Apr 2013
Pg. 165-167
|
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
|
Jan/Feb 2013
Pg. 10-22
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2013
Pg. 28-38
|
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
|
Nov/Dec 2012
Pg. 462-469
|
Colds and Cough
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 480-483
|
Stability of Ursodiol in SyrSpend SF Cherry Flavored
Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
|
Nov/Dec 2012
Pg. 510-512
|
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations
Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
|
Nov/Dec 2012
Pg. 516-523
|
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
|
Sep/Oct 2012
Pg. 386-393
|
Calculations
Stockton Shelly J
|
Sep/Oct 2012
Pg. 416
|
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Peacock Gina F, Sauvageot Jurgita
|
Sep/Oct 2012
Pg. 428-430
|
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization
Radojkovic Branko, Milic Jela, Calija Bojan
|
Sep/Oct 2012
Pg. 434-437
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A, Allen Loyd V Jr
|
May/Jun 2012
Pg. 210-218
|
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream
Lehman Paul A, Raney Sam G
|
May/Jun 2012
Pg. 248-252
|
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris, Delano Amy
|
Mar/Apr 2012
Pg. 110-114
|
Chemical Stability of Pentoxifylline in a Topical Cream
Gupta Vishnu D
|
Jan/Feb 2012
Pg. 80-81
|
Vitamins: Therapy or Hype
Wynn Tom, Hoffrogge Zach
|
Jan/Feb 2012
Pg. 17-21
|
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2012
Pg. 62-63
|
Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
|
Nov/Dec 2011
Pg. 450-457
|
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
|
Nov/Dec 2011
Pg. 458-463
|
Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D, Williams LaVonn
|
Nov/Dec 2011
Pg. 464-469
|
Calculations
Stockton Shelly J
|
Nov/Dec 2011
Pg. 498
|
Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 500
|
Citric Acid 3% Mouthrinse Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 501
|
Dapsone 5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 502
|
Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 503
|
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 507
|
Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 508
|
Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 509
|
A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard
Walker Heather, Sridhar Vishak, Alexander Kenneth S
|
Nov/Dec 2011
Pg. 510-514
|
Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant
Jha Antesh Kr, Chetia D
|
Nov/Dec 2011
Pg. 521-525
|
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions
McElhiney Linda F
|
Sep/Oct 2011
Pg. 376-380
|
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
|
Sep/Oct 2011
Pg. 386-387
|
Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 418
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 420
|
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 421
|
Nifedipine 1-mg/500-mg Oral Powder
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 422
|
Nifedipine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 423
|
Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 424
|
Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 425
|
Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 426
|
Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 427
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Magnesium Sulfate Paste
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 339
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
|
May/Jun 2011
Pg. 194-199
|
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom, Goetsch Daniel
|
May/Jun 2011
Pg. 200-203
|
Treatment Options for Psoriasis
Williams LaVonn A, Humphreys Erica
|
May/Jun 2011
Pg. 204-213
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 242
|
Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 243
|
Ibuprofen 5% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 244
|
Sport Body Cooler
Allen Loyd V Jr
|
May/Jun 2011
Pg. 247
|
Tannic Acid 5% Alcohol Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 248
|
Triamcinolone 0.1% Lotion
Allen Loyd V Jr
|
May/Jun 2011
Pg. 249
|
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 245
|
Triclosan 2% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 250
|
Wound Cleaner Solution
Allen Loyd V Jr
|
May/Jun 2011
Pg. 251
|
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John, DollbaumCharles M
|
Mar/Apr 2011
Pg. 102-112
|
Mandl's Paint
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 162
|
Oral Film Strip Vehicle
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 164
|
Tea Tree Oil Acne Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 165
|
Nifedpine in Compounded Oral and Topical Preparations
McCluskey Susan V, Brunn Gregory J
|
Mar/Apr 2011
Pg. 166-169
|
PostScription: Commentary: Discussion on the Safety of Topical Prilocaine
Bramwell Bethany L
|
Mar/Apr 2011
Pg. 174-175
|
Current Concepts in the Treatment of Recurrent Aphthous Ulcers
Bramwell Bethany L, Williams LaVonn A
|
Jan/Feb 2011
Pg. 13-18
|
Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
|
Jan/Feb 2011
Pg. 27-31
|
Toxicities Associated with Topical Anesthetics
Bramwell Bethany L
|
Jan/Feb 2011
Pg. 41
|
Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 64
|
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 65
|
Ibuprofen 5% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 66
|
Mandelic Acid 5% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 67
|
Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 68
|
Piroxicam 1% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 69
|
Pramoxine 1% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 70
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 72
|
Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 73
|
Stability of Midazolam Intranasal Formulation for the Treatment of Status Epilepticus in Dogs
Elder Deborah Lester, Zheng Bo, White Catherine A, Li Dawei
|
Jan/Feb 2011
Pg. 74-77
|
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding
Williams KaCee D
|
Nov/Dec 2010
Pg. 484-486
|
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara, Browne Paul
|
Nov/Dec 2010
Pg. 488-491
|
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 512
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 514
|
Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 517
|
Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 518
|
Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 519
|
Ketoprofen 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 521
|
Extemporaneous Compounding of Medicated Ointment
Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
|
Nov/Dec 2010
Pg. 472-478
|
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care
Cox Chris
|
Nov/Dec 2010
Pg. 480-483
|
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 520
|
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa, Pankaskie Marvin, Birnie Christine
|
Nov/Dec 2010
Pg. 522-525
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients
Muller George, Case Tyler, Deen Griffin L
|
Sep/Oct 2010
Pg. 395-399
|
Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 420
|
Icy Blue Camphorated Gel
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 422
|
Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 423
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Triclosan 0.28% Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 425
|
Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 426
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 428
|
Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 429
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Recommendations for Compounding Medications for Feeding Tube Administration
Klang Mark
|
Jul/Aug 2010
Pg. 276-282
|
Considerations for Percutaneous Absorption
Newton Stephen J, Cook Jennifer M
|
Jul/Aug 2010
Pg. 301-304
|
Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 334
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 322-326
|
Ampicillin 250-mg Suppository
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 335
|
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 336
|
Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 341
|
Evaluation of Extemporaneous Oral Itraconazole Suspensions by Dissolution Profiles Mapping
Tong Henry H Y, Chan Hokman, Du Zhen, Zheng Ying
|
Jul/Aug 2010
Pg. 342-345
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Managing Pain with Transdermal Ketoprofen
Williams KaCee D
|
May/Jun 2010
Pg. 204-206
|
Potential Treatments for Radiation Dermatitis
Corsini Lindsay
|
May/Jun 2010
Pg. 210-213
|
Calculations
Stockton Shelly J
|
May/Jun 2010
Pg. 230
|
Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2010
Pg. 240
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 241
|
Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 242
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 243
|
Cohen's Rectal Ointment
Allen Loyd V Jr
|
May/Jun 2010
Pg. 244
|
Cyclophosphamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 245
|
Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 246
|
Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 247
|
Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 248
|
Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 249
|
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
|
May/Jun 2010
Pg. 250-256
|
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
|
Mar/Apr 2010
Pg. 112-115
|
Acyclovir 5% in Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 150
|
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 151
|
Ciclopirox 10% in Isopropyl Alcohol Nail Solution
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 152
|
Clotrimazole 1% Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 153
|
Cyclosporin 10-mg/g in Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 154
|
Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 155
|
Plasticized Hydrocarbon Gel
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 158
|
Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 159
|
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010
Pg. 21-25
|
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
|
Jan/Feb 2010
Pg. 40-45
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Metronidazole in Normal Saline Enema
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 69
|
Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 70
|
Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 72
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 73
|
Trigger Point Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 75
|
When Traditional Medicine Fails
Bash Robert
|
Jan/Feb 2010
Pg. 6-8
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 74
|
Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 554
|
Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 555
|
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
|
Nov/Dec 2009
Pg. 540-543
|
Ichthammol 10% Otic Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 557
|
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J, Asbill Scott
|
Nov/Dec 2009
Pg. 569-571
|
Lubow's Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 558
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 559
|
Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 560
|
Twevan Cream
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 561
|
Voriconazole 2% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 562
|
Stability of Preoperative Cataract Surgery Gel in Polycarbonate Syringes
Bailey Caroline, Aloumanis Vasileios, Walker Brian, Ben Michel, McGuire Jason, Vu Nicole
|
Nov/Dec 2009
Pg. 564-568
|
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Parish Roy C
|
Nov/Dec 2009
Pg. 572-573
|
Transdermal Dosing Considerations for Veterinarians
Williams KaCee D
|
Sep/Oct 2009
Pg. 358-360
|
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A, Riley Kari
|
Sep/Oct 2009
Pg. 367-371
|
Recommended Tips for Treating Veterinary Patients
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009
Pg. 390-391
|
Aceclofenac 1.5% Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 428
|
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 432
|
Lidocaine 10% Oral Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 433
|
Mechlorethamine Hydrochloride 0.02% Topical
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 434
|
Myristyl Nicotinate 5% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 435
|
Nitroglycerin 4-mg Suppository
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 436
|
Chemical Stability of Scopolamine Hydrobromide Nasal Solution
Gupta Vishnu D
|
Sep/Oct 2009
Pg. 438-439
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
Moxifloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 337
|
Mupirocin 1% (20-mg) Vaginal Suppository
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 338
|
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 340
|
Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison
Chauhan Harsh, Atef Eman
|
Jul/Aug 2009
Pg. 342-344
|
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
|
Jul/Aug 2009
Pg. 345-349
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jul/Aug 2009
Pg. 270-275
|
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
|
Jul/Aug 2009
Pg. 276-279
|
Alcohol-based Carbomer Gel
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 332
|
Benzoyl Peroxide 10% Gel
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 333
|
Clindamycin 100-mg Vaginal Suppositories
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 334
|
Dexamethasone and Furosemide Injection
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 335
|
Formulation Optimization Study for an Immediate-Release Tablet
Kyriacos Soula, Dimassi Hani
|
May/Jun 2009
Pg. 259-261
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids
Zur Eyal
|
May/Jun 2009
Pg. 192-195
|
Missives from Iraq: Compounding the Theatre of War--Phenytoin Solution Heals Severe Refractory Wounds: An Anecdotal Report
Muller George, Hall Linda A, Stovall Audrey, Peters Susan H, Vail Jane
|
May/Jun 2009
Pg. 196-213
|
Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L, Bogner Robin H
|
May/Jun 2009
Pg. 214-217
|
Safe Use of Topical Local Anesthetic Medications for Pain Management
Epshteyn Mikhail G, Pepin Steven M
|
May/Jun 2009
Pg. 218-219
|
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
|
May/Jun 2009
Pg. 220-221
|
Analgesic Compound Lotion, Clear
Allen Loyd V Jr
|
May/Jun 2009
Pg. 240
|
Hydromorphone Hydrochloride 10-mg/mL Oral Drops
Allen Loyd V Jr
|
May/Jun 2009
Pg. 241
|
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A Comparison of Two Methods of Compounding
Garg Sanjay, Svirskis Darren, Al-Kabban Majid, Farhan Samer, Komeshi Mohammed, Lee Jacky, Liu Quincy, Naidoo Sacha, Kairuz Therese
|
May/Jun 2009
Pg. 250-253
|
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Shank Brandon R, Ofner Clyde M III
|
May/Jun 2009
Pg. 254-258
|
Lidocaine 2% Popsicle
Allen Loyd V Jr
|
May/Jun 2009
Pg. 242
|
Morphine Sulfate 10-mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2009
Pg. 243
|
Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
May/Jun 2009
Pg. 244
|
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
May/Jun 2009
Pg. 245
|
Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules
Allen Loyd V Jr
|
May/Jun 2009
Pg. 246
|
Oxycodone Hydrochloride 20-mg Suppository
Allen Loyd V Jr
|
May/Jun 2009
Pg. 247
|
Promethazine 20-mg and Acetaminophen 325-mg Suppositories
Allen Loyd V Jr
|
May/Jun 2009
Pg. 248
|
Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules
Allen Loyd V Jr
|
May/Jun 2009
Pg. 249
|
Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule
Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
|
Mar/Apr 2009
Pg. 170-174
|
Aprepitant 20-mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 153
|
Chloroquine Phosphate 64.5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 154
|
Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 155
|
Ionic Hydration Solution for Anti-Cancer Therapy
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 156
|
Metronidazole 2.1-mg/mL in 5.25% Dextrose Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 157
|
Nicotine Rectal Enema
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 158
|
Thiothixene Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 159
|
Tolterodine 2-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 160
|
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 161
|
Compounding for Pediatric Patients: Case Reports and Formulations
Mixon William, Angelle Patricea, Yoch Douglas
|
Jan/Feb 2009
Pg. 6-12
|
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Compounding with Sucralfate for the Treatment of External Wounds
Wynn Tom, Williams LaVonn A
|
Jan/Feb 2009
Pg. 25-29
|
Identifying the Criteria of a Valid Stability Study
Williams LaVonn A, Hastings Mitchell Blaine
|
Jan/Feb 2009
Pg. 32-36
|
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 64
|
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 65
|
Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 66
|
Dextromethorphan Hydrobromide 30-mg Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 67
|
Diaper Rash Cream with Miconazole
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 68
|
Diphenhydramine Hydrochloride 25-mg Gelatin Troches
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 69
|
Electrolyte Lollipop (Adult)
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 70
|
Hydrogen Peroxide 1.5% and Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 71
|
Peruvian Balsam, Zinc Stearate, Boric Acid, and Talcum Powder
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 72
|
Tetracaine 0.025% Popsicles
Allen Loyd V Jr
|
Jan/Feb 2009
Pg. 73
|
Testing of Estradiol in a Compounded Cream and a Stock Solution
Buderer Matthew J, Buderer Nancy M
|
Jan/Feb 2009
Pg. 74-77
|
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William, Helms Scott R
|
Sep/Oct 2008
Pg. 392-397
|
Aceclofenac 1.5% Gel-Cream
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 446
|
Acetaminophen 10-mg/mL Rectal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 447
|
Dichlorobenzyl Alcohol Tooth Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 449
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
Flurandrenolide Topical Film
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 451
|
Ketoprofen 20% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 452
|
Lidocaine Adhesive System Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 453
|
Piroxicam 5% and Dexpanthenol 5% Gel
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 454
|
Propafenone 1.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 455
|
Compounding Challenges for Immunocompromised Patients
McElhiney Linda F
|
Nov/Dec 2008
Pg. 482-487
|
Case Reports: Compounding to Relieve Arthritis Pain
Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
|
Nov/Dec 2008
Pg. 498-504
|
Indomethacin 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 543
|
Ketorolac Tromethamine 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 544
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 540
|
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 541
|
Morphine Sulfate 20-mg and Prochlorperazine Maleate 10-mg Troches
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 549
|
Zirconium Oxide Lotion
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 364
|
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada
Prot-Labarthe Sonia, Bussieres Jean-Francois, Barett Pierre, Bourdon Olivier, Brion Francoise
|
Jul/Aug 2008
Pg. 365-367
|
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms
Gupta Vishnu D
|
Jul/Aug 2008
Pg. 372-374
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
Quality-Control Analytical Methods: Homogeneity of Dosing Forms
Kupiec Thomas C, Vu Nicole, Branscum David
|
Jul/Aug 2008
Pg. 340-343
|
Chloroxylenol 1% and Chlorhexidine Diacetate 1% Topical Powder
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 355
|
Silicone Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 356
|
Sodium Chloride 0.9% Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 357
|
Squalene 0.2% Cream
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 358
|
Sucralfate and Hyaluronic Acid Ointment
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 359
|
Tretinoin and (-)Alpha-Bisabolol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 360
|
Tretinoin and Dexpanthenol Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 361
|
Ultrasonic Adhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 362
|
Vitamin A Suppository
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 363
|
African Scalp Lotion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 260
|
Benzyl Benzoate Lotion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 261
|
Calcium Gluconate 2.5% Topical Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 262
|
Lubricating Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 263
|
Meloxicam 0.3% Topical Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 264
|
Miconazole Nitrate 2%, Deoxy-D-Glucose 0.2%, and Hydrocortisone 0.4% Lip Balm
Allen Loyd V Jr
|
May/Jun 2008
Pg. 265
|
Potassium Nitrate/Benzocaine/Tetracaine Dental Gel
Allen Loyd V Jr
|
May/Jun 2008
Pg. 266
|
Promethazine Hydrochloride 2.5-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2008
Pg. 267
|
Tolnaftate 1% Antifungal Microemulsion
Allen Loyd V Jr
|
May/Jun 2008
Pg. 268
|
Valsartan 4-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2008
Pg. 269
|
Topical Treatment of Neuropathic Pain
Vadaurri Vince
|
May/Jun 2008
Pg. 182-190
|
Compounded Local Anesthetics to Minimize Pain from Medical Procedures
McElhiney Linda F
|
May/Jun 2008
Pg. 192-197
|
Dilution and Compounding of Ziconotide for Intrathecal Administration
Buchta Tony, Fakata Keri, Stuart William
|
May/Jun 2008
Pg. 200-207
|
Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model
Bassani August S, Banov Daniel, Lehman Paul A
|
May/Jun 2008
Pg. 270-273
|
Acyclovir 5% Topical Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 146
|
Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting
de Oliveira Ferreira Anderson, Holandino Carla
|
Mar/Apr 2008
Pg. 163-169
|
Alum 6.5% Topical Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 147
|
Aminacrine Hydrochloride 0.1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 148
|
Butesin Picrate 1% ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 149
|
Carbamazepine Topical Preparations
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 150
|
Chlorhexidine Gel
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 151
|
EDTA 1% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 152
|
Erythromycin 1% and Neomycin Sulfate Ointment
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 153
|
Heparin Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 154
|
Hydrogen Peroxide 8% Cream
Allen Loyd V Jr
|
Mar/Apr 2008
Pg. 155
|
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration
Dib Jean G, Abdulmohsin Saud
|
Jan/Feb 2008
Pg. 8-14
|
Cyclosporine Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 64
|
Diclofenac Sodium 1% Soft-Patch Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 65
|
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 66
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 67
|
Emetine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 68
|
Flosulide 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 69
|
Pentoxifylline 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 70
|
Piroxicam 1% Soft-Patch Lipophilic Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 71
|
Piroxicam 1% Soft-Patch Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 72
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2008
Pg. 73
|
Aloe Vera Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 504
|
Breast Care Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 505
|
Castor Oil and Trypsin Ointment
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 506
|
Topical Pain Relief: Assessment of Patient Satisfaction with a Novel Compound Containing at Least Ketoprofen
Zugerman Jessie Jean M, Reed Thomas C
|
Nov/Dec 2007
Pg. 514-519
|
Chlorhexidine 2% Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 507
|
Coal Tar 2% and Allantoin 2.5% Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 508
|
Foscarnet 2.5% Topical Cream
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 509
|
Interferon alfa-2b Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 510
|
Miconazole 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2007
Pg. 512
|
Rabbit Medicine
Jordan Dinah G
|
Sep/Oct 2007
Pg. 364-374
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Betamethasone Valerate 0.1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 419
|
Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 420
|
Diclofenac Sodium 75-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 421
|
Hydrocortisone 0.5% Ethanolic Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 423
|
Neomycin 0.05% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 424
|
Isoniazid Release from Suppositories Compounded with Selected Bases
Hudson Kristofer C, Asbill C Scott, Webster Andrew A
|
Sep/Oct 2007
Pg. 433-437
|
Ketoconazole 25-mg Liquid Suppository
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 329
|
Mebeverine Hydrochloride 20% gel
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 330
|
Oseltamivir 12-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 332
|
Phenytoin Sodium 20-mg/mL Topical Suspension
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 333
|
Vehicle N Formulas
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 337
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
May/Jun 2007
Pg. 220-225
|
Calculations - Compounding for Pain Management
Stockton Shelly J
|
May/Jun 2007
Pg. 238-239
|
Benazepril 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 242
|
Cholecalciferol 40,000-IU/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 243
|
Folic Acid 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 244
|
Glycopyrrolate 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 245
|
Isoproterenol Compound Elixir
Allen Loyd V Jr
|
May/Jun 2007
Pg. 246
|
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 248
|
Methylphenidate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 249
|
Thiamine Hydrochloride 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 250
|
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 251
|
Transdermal Gel in the Treatment of Postoperative Pain
Alexander Kayla, Wynn Tom
|
May/Jun 2007
Pg. 181-184
|
Oral Methadone for Management of Regional Sympathetic Dystrophy Syndrome: A Case Revisited
Vail Jane
|
May/Jun 2007
Pg. 187-192
|
The Rectal Rocket: A Two-Day Treatment for Hemorrhoids
Vail Jane
|
May/Jun 2007
Pg. 194-199
|
Insulins: Historical and Current Perspectives
Vance Dwight A
|
Mar/Apr 2007
Pg. 95-104
|
Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh
Vail Jane
|
Mar/Apr 2007
Pg. 106-110
|
Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes
Fields Shannon W
|
Mar/Apr 2007
Pg. 122-124
|
Case Report: Shingles Triple Cream in the Treatment of Herpes Zoster
Fields Shannon W
|
Mar/Apr 2007
Pg. 131
|
Quality Control Analytical Methods: Considerations in Compounding Peroral Solid Dosage Forms
Vu Nicole
|
Mar/Apr 2007
Pg. 145-148
|
Innovative Uses of Compounded Tranilast: An Interview with Compounding Pharmacist Larry J. Frieders, RPh
Vail Jane
|
Mar/Apr 2007
Pg. 132-135
|
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1
Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
|
Jan/Feb 2007
Pg. 5-8
|
Pediatric Oral Formulations: A Continual Challenge
Hurtado Josephine, Moffett Brady S
|
Jan/Feb 2007
Pg. 17-19
|
Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
|
Jan/Feb 2007
Pg. 27
|
Caffeine Citrate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 69
|
Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 70
|
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 71
|
Dexamethasone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 72
|
Fluoxetine Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 73
|
Lansoprazole 3-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 74
|
Methyldopa 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 75
|
Metolazone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2007
Pg. 76
|
Chemical Stability of Desonide in Ear Drops
Gupta Vishnu D
|
Jan/Feb 2007
Pg. 79-81
|
BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle
Benischek Rita L
|
Nov/Dec 2006
Pg. 428-433
|
Ronidazole in the Treatment of Trichomonad Infections in Cats
Davidson Gigi S
|
Nov/Dec 2006
Pg. 434-435
|
Chloral Hydrate 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 453
|
Cyclophosphamide 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 454
|
Disulfiram 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 455
|
Gabapentin 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 456
|
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 457
|
Indomethacin 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 458
|
Naltrexone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 459
|
Terbutaline Sulfate 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 460
|
Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 461
|
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc
|
Nov/Dec 2006
Pg. 469-477
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Compounding for Veterinary Medicine
Fields Shannon W
|
Nov/Dec 2006
Pg. 417-418
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Taurine for the Treatment of Canine Dilated Cardiomyopathy
Vail Jane
|
Nov/Dec 2006
Pg. 421-424
|
Amiloride Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2006
Pg. 452
|
Topical Cidofovir for Treatment of Resistant Viral Infections
McElhiney Linda F
|
Sep/Oct 2006
Pg. 324-328
|
Dermatological Effects from Years in the Sun: Compounding Opportunities
Jones Marty
|
Sep/Oct 2006
Pg. 336-342
|
Case Report: Treatment of Migraines with Compounded Piroxicam Mini-Troches
Williams Steve D
|
Sep/Oct 2006
Pg. 351
|
In Vitro Transdermal Diffusion of Zileuton from a Topical Gel
Bigeleisen Paul E
|
Sep/Oct 2006
Pg. 392-395
|
Temozolomide Stability in Extemporaneously Compounded Oral Suspensions
Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
|
Sep/Oct 2006
Pg. 396-399
|
Compounded Treatment Options for Cystitis and Other Bladder Problems
McElhiney Linda F
|
Jul/Aug 2006
Pg. 270-275
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Adderall 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 299
|
Dapsone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 300
|
Itraconazole 40-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 301
|
Lisinopril 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 302
|
Nifedipine 4-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 303
|
Propranolol Hydrochloride 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 304
|
Sildenafil Citrate 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 306
|
Tramadol Hydrochloride 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 307
|
Tramadol Hydrochloride 7.5-mg/mL and Acetaminophen 65-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2006
Pg. 308
|
Stability of Memantine in an Extemporaneously Prepared Oral Liquid
Yamreudeewong Weeranuj, Teixeira M Glaucia, Mayer Gabriele E
|
Jul/Aug 2006
Pg. 316-317
|
Prevention of Preterm Delivery with Compounded 17a-Hydroxyprogesterone Caproate
Reed-Kane Dana, Kirshbaum Karen
|
May/Jun 2006
Pg. 165-171
|
Quality-Control Analytical Methods: Particulate Matter in Injections: What is It and What are the Concerns?
Tran Tuan, Kupiec Thomas C, Trissel Lawrence A
|
May/Jun 2006
Pg. 202-204
|
Basics of Compounding for Dentistry, Part 2: Tooth Whitening
Fonseca Simonne C
|
May/Jun 2006
Pg. 205-207
|
Triamcinolone Acetonide 0.1% Mouthwash Solution
Allen Loyd V Jr
|
May/Jun 2006
Pg. 229
|
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
|
Mar/Apr 2006
Pg. 147-153
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
Basics of Compounding for Dentistry, Part 1: Effective Approaches and Formulations
Fonseca Simonne C
|
Mar/Apr 2006
Pg. 122-127
|
Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
|
Jan/Feb 2006
Pg. 9-11
|
Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery
Heim Bob
|
Jan/Feb 2006
Pg. 14-18
View Sample |
Chlorambucil 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 59
|
Dantrolene Sodium 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 60
|
Domperidone 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 61
|
Efavirenz 20-mg/mL Oral Liquid, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 62
|
Medium-Chain Triglycerides Oral Vehicle, Anhydrous
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 63
|
Mercaptopurine 50-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 64
|
Misoprostol 1-mg Suppository
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 65
|
Naratriptan Hydrochloride 0.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 66
|
Propylthiouracil 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 67
|
Thioguanine 40-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2006
Pg. 68
|
Prescription: Pediatric Formulation Initiatives
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 410
|
Unlocking Autism: Is Compounding the Key?
Vail Jane
|
Nov/Dec 2005
Pg. 413-420
|
Compounding for a Pediatric Hospital
McElhiney Linda F
|
Nov/Dec 2005
Pg. 423-431
|
Wiping Out Diaper Rash
Fields Shannon W
|
Nov/Dec 2005
Pg. 433-434
View Sample |
Pediatric Oral Liquid Preparations
Fonseca Simonne C, Ferreira Anderson de O
|
Nov/Dec 2005
Pg. 437-442
|
Alprazolam 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 472
|
Bethanechol 5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 473
|
Clonazepam 0.1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 474
|
Dolasetron 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 475
|
Ganciclovir 100-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 476
|
Isradipine 1-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 477
|
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions
Fonseca Simonne C
|
Nov/Dec 2005
Pg. 456-461
|
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 462-469
|
Pyrazinamide 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 478
|
Quinidine Sulfate 10-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 479
|
Ursodiol 25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 480
|
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2005
Pg. 481
|
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms
Gupta Vishnu D
|
Nov/Dec 2005
Pg. 484-486
|
A Patient's Guide to Transdermal Treatment of Pain
Fields Shannon W
|
Sep/Oct 2005
Pg. 354
|
Update on Transdermals for Animal Patients
Davidson Gigi S
|
May/Jun 2005
Pg. 178-182
View Sample |
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions
Fonseca Simonne C
|
May/Jun 2005
Pg. 215-218
|
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study
Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
|
May/Jun 2005
Pg. 242-246
|
| Return to Top |
